By Drug Class / Mechanism

Whole-Exome Sequencing (WES) Market Analysis

Cross-industry research covering Whole-Exome Sequencing (WES) across 1 market reportspanning Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics.

1 Reports

1 Industries

Reports Covering Whole-Exome Sequencing (WES)

Direct to Consumer Genetic Sequencing Market to Reach USD 4.7 Billion by 2033 at 7.2% CAGR

Pharmaceuticals & Life Sciences – Molecular Diagnostics / Consumer Genomics·Market: USD 2.7 Billion (2025)·CAGR: 7.2%

WES is gaining ground in rare disease diagnosis and pediatric carrier screening, where the completeness of exonic coverage justifies the USD 200–400 consumer price. Integration with clinical EMR workflows is accelerating adoption by health system-affiliated DTC programs.

14%

Market Share

9.5%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments